Welcome to our dedicated page for Resonate Blends news (Ticker: KOAN), a resource for investors and traders seeking the latest updates and insights on Resonate Blends stock.
Apollo Biowellness, Inc. (KOAN), formerly Resonate Blends, Inc., reports corporate updates tied to biologic-based consumer and professional products. News for the OTC Pink issuer centers on its subsidiary Evolutionary Biologics, the Evo Bio brand, licensed natural stem cell mobilizing agents, a dual-acting natural diet aid, and biologic cosmetics such as Cielo Skin Care.
Recurring developments include distribution agreements for medical-spa, dermatology, plastic-surgery and aesthetic-clinician channels, product-brand announcements, OTCIQ disclosure status, creditor and capital-structure updates, and management changes. Company releases also describe efforts to market biologic products through retail, e-commerce, direct-to-consumer and professional distribution channels.
Resonate Blends, Inc. (OTCQB:KOAN) is sponsoring the Revival Stage at the 'Luck Summit: Planting the Seed' cannabis conference from April 26 to April 29. With keynotes from Willie Nelson and Steven Hawkins, the event aims to educate and destigmatize cannabis. KOAN® Cordials will be presented in a virtual booth, marking their public debut. The summit includes panels, music, and health-related activities. Resonate's CEO highlighted the event as pivotal for introducing their products to industry leaders and consumers.
Resonate Blends, Inc. (OTCQB:KOAN) has successfully closed a private placement, raising $3,312,500 in gross proceeds. After finder fees, the net capital is $3,024,287, which will support the launch of the company's KOAN® Cordials. The funds are also allocated to retire remaining Promissory Convertible Notes and for general working capital. The company is gearing up for full-scale production of the six unique KOAN® Cordials formulations, aiming to align its capital structure with product launch needs.
Resonate Blends, Inc. (OTCQB:KOAN) announces the launch of its first product, the THC-based Koan Cordials, aimed at the wellness lifestyle market. Set to ship in Q1 next year, the cordials are designed for targeted experiences. The company is actively preparing for distribution and marketing while exploring licensing opportunities in cannabis-friendly states. A successful 506(c) offering has provided the capital needed for launch, with plans to improve the balance sheet and foster growth. Resonate is focused on innovative cannabis products and expanding its market reach.